Compound Detail
CHEMBL975
MESNA 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL975 |
| Name | MESNA |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | XOGTZOOQQBDUSI-UHFFFAOYSA-M |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1098319 |
| Active Moiety | CHEMBL1098319 |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
20
Publications
8
Known Names
20
Indications
1
Mechanisms
Molecular Properties
142.2
MW (Da)
-0.20
ALogP
3
HBA
2
HBD
54.4
PSA (Ų)
0.41
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1988 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Unknown | - | - | ✓ | ✓ |
Indications
Thrombocytopenia Brain Neoplasms Breast Neoplasms Breast Neoplasms Ependymoma Ependymoma Leukemia Leukemia, Lymphoid Lung Neoplasms Lymphoma Lymphoma, Large B-Cell, Diffuse Medulloblastoma Multiple Sclerosis, Relapsing-Remitting Neuroblastoma Sarcoma Sarcoma Scleroderma, Systemic Acute Kidney Injury Anemia, Aplastic Anemia, Sickle Cell
ATC Classification
R05CB05
mesna
Level 1: RESPIRATORY SYSTEM
Level 2: COUGH AND COLD PREPARATIONS
V03AF01
mesna
Level 1: VARIOUS
Level 2: ALL OTHER THERAPEUTIC PRODUCTS
Literature References
Data from ChEMBL 36 via Core Engine